A previous study demonstrated lower CSF Aβ-42 levels in carriers of the ε4 allele of the apolipoprotein E (APOE) gene [59], but recent data show that this is mediated via the association of ε4 with senile plaque pathology in Alzheimer’s disease [60]. This evidence concerns the gene APOE and Alzheimer disease.